Ocean Power Technologies Inc (NYSE-A:OPTT) announced that it has secured a new contract with an international government client for the near-term delivery of a fully integrated Wave Adaptive Modular Vessel (WAM-V).Assembly of the vehicle is already underway, with shipment and in-country training and support to follow.
"Securing this contract is testament to demand for our systems in the market,” OPT chief executive Philipp Stratmann said in a statement. “Recent efforts in Latin America and the Middle East are continuing to drive interest in our systems.”
Caledonia Mining Corporation PLC (AIM:CMCL, NYSE-A:CMCL) confirmed it has now completed the sale of its solar plant for $22.35 million.
It sold the subsidiary that owns and operates a 12.2MWac solar plant that continues to supply power to the Blanket Mine under an exclusive power purchase agreement.
Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF) shares climbed 19% on Monday after the company announced a partnership with the NHS Cancer Vaccine Launch Pad to speed up recruitment for the next phase of its melanoma trial.
The initiative will fast-track eligible NHS patients into the fourth cohort of Scancell’s ongoing phase II SCOPE study, which is testing iSCIB1+, a DNA-based cancer vaccine delivered into the skin alongside standard immunotherapy. The study is coordinated by the Southampton Clinical Trials Unit.
Anglo Asian Mining PLC (AIM:AAZ, OTC:AGXKF) told investors it produced 8,085 gold equivalent ounces in the first quarter of 2025 – it’s the first full quarter of operations since the mine’s shutdown in 2023.
Production comprised 6,029 ounces of gold, 534 tonnes of copper, and 30,321 ounces of silver.
Pantheon Resources PLC (AIM:PANR, OTCQX:PTHRF) has released preliminary results at the Megrez-1 well, where the testing in the first of multiple zones has disappointed.
In the Megrez well the Topset 1 reservoir was stimulated across a 290-foot section, but initial results indicated that, at this location, it is in a transition zone with insufficient mobile oil.
Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF), a London-listed biotech focused on longevity, has signed a partnership deal with US artificial intelligence firm Heureka Labs to help sharpen its gene therapy research.
The agreement, finalised on April 11, sets up a long-term collaboration between the two companies.
Sharess in Ananda Pharma Plc (AQSE:ANA), a UK-based biopharmaceutical company developing cannabis-derived medicines, will later today start trading in the United States.
That's because its stock will be available to American investors on the OTCQB Venture Market, under the ticker symbol ANANF. It will continue to trade on the Aquis Stock Exchange in London, where the company has its primary listing.
Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF) has partnered with the NHS Cancer Vaccine Launch Pad to accelerate recruitment for the next phase of its clinical trial in advanced melanoma.
The company said on Monday that eligible NHS patients will be fast-tracked into the fourth cohort of its ongoing phase II SCOPE study, which is evaluating iSCIB1+, a DNA-based cancer vaccine delivered intradermally. Patients in this cohort will also be receiving standard immunotherapy treatments.
Orthocell Ltd finished the March 2025 quarter with major progress towards commercialising its regenerative medicine portfolio, headlined by the post-quarter US Food and Drug Administration (FDA) clearance for its flagship Remplir™ nerve repair device.
Clearance for Remplir™ under the FDA’s 510(k) pathway was granted on April 3, 2025, positioning the company to begin distribution into the US$1.6 billion nerve repair market. With logistics and sales pathways already in place and a US-based commercial team active since November 2024, Orthocell expects to generate its first US revenue from Remplir™ within the current financial year.
Buru Energy Ltd's transformation from explorer to producer is progressing well, setting a clear pathway to deliver first gas and cashflow from its flagship Rafael Gas Project in the Kimberley region by the second half of 2027.
Located in the Canning Basin, Rafael is the only proven conventional gas and condensate discovery in the Kimberley.
Elixir Energy Ltd has appointed Stuart Nicholls as managing director and CEO, following the retirement of Neil Young.
The leadership change comes as the company advances its transition from exploration to development at the Grandis gas project in Queensland’s Taroom Trough.